Semiconductors
Compare Stocks
5 / 10Stock Comparison
CRUS vs SYNA vs MCHP vs MTSI vs ADI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
CRUS vs SYNA vs MCHP vs MTSI vs ADI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $8.76B | $4.13B | $54.97B | $25.84B | $199.44B |
| Revenue (TTM) | $2.00B | $1.17B | $4.37B | $1.07B | $11.76B |
| Net Income (TTM) | $414M | $-48M | $-97M | $177M | $2.71B |
| Gross Margin | 52.8% | 43.6% | 51.6% | 55.3% | 62.8% |
| Operating Margin | 23.0% | -6.4% | 4.1% | 16.0% | 29.2% |
| Forward P/E | 18.9x | 23.9x | 64.8x | 76.9x | 35.8x |
| Total Debt | $134M | $880M | $5.67B | $538M | $8.66B |
| Cash & Equiv. | $801M | $392M | $772M | $112M | $2.50B |
CRUS vs SYNA vs MCHP vs MTSI vs ADI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cirrus Logic, Inc. (CRUS) | 100 | 236.9 | +136.9% |
| Synaptics Incorpora… (SYNA) | 100 | 166.0 | +66.0% |
| Microchip Technolog… (MCHP) | 100 | 211.6 | +111.6% |
| MACOM Technology So… (MTSI) | 100 | 1084.9 | +984.9% |
| Analog Devices, Inc. (ADI) | 100 | 361.7 | +261.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRUS vs SYNA vs MCHP vs MTSI vs ADI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRUS carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 1.12, Low D/E 6.3%, current ratio 7.37x
- PEG 1.06 vs ADI's 5.25
- Beta 1.12, current ratio 7.37x
- Lower P/E (18.9x vs 35.8x), PEG 1.06 vs 5.25
Among these 5 stocks, SYNA doesn't own a clear edge in any measured category.
MCHP ranks third and is worth considering specifically for income & stability.
- Dividend streak 5 yrs, beta 1.70, yield 1.8%
- 1.8% yield, 5-year raise streak, vs ADI's 0.9%, (3 stocks pay no dividend)
MTSI is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 8.0% 10Y total return vs ADI's 6.9%
- 32.6% revenue growth vs MCHP's -42.3%
- +203.8% vs CRUS's +77.6%
ADI is the clearest fit if your priority is growth exposure.
- Rev growth 16.9%, EPS growth 39.0%, 3Y rev CAGR -2.8%
- 23.0% margin vs SYNA's -4.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.6% revenue growth vs MCHP's -42.3% | |
| Value | Lower P/E (18.9x vs 35.8x), PEG 1.06 vs 5.25 | |
| Quality / Margins | 23.0% margin vs SYNA's -4.1% | |
| Stability / Safety | Beta 1.12 vs SYNA's 2.28, lower leverage | |
| Dividends | 1.8% yield, 5-year raise streak, vs ADI's 0.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +203.8% vs CRUS's +77.6% | |
| Efficiency (ROA) | 17.1% ROA vs SYNA's -1.9%, ROIC 22.9% vs -4.0% |
CRUS vs SYNA vs MCHP vs MTSI vs ADI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CRUS vs SYNA vs MCHP vs MTSI vs ADI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CRUS leads in 2 of 6 categories
ADI leads 1 • MTSI leads 1 • SYNA leads 0 • MCHP leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ADI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADI is the larger business by revenue, generating $11.8B annually — 10.9x MTSI's $1.1B. ADI is the more profitable business, keeping 23.0% of every revenue dollar as net income compared to SYNA's -4.1%. On growth, ADI holds the edge at +30.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.0B | $1.2B | $4.4B | $1.1B | $11.8B |
| EBITDAEarnings before interest/tax | $486M | $50M | $881M | $210M | $5.4B |
| Net IncomeAfter-tax profit | $414M | -$48M | -$97M | $177M | $2.7B |
| Free Cash FlowCash after capex | $637M | $97M | $820M | $168M | $4.6B |
| Gross MarginGross profit ÷ Revenue | +52.8% | +43.6% | +51.6% | +55.3% | +62.8% |
| Operating MarginEBIT ÷ Revenue | +23.0% | -6.4% | +4.1% | +16.0% | +29.2% |
| Net MarginNet income ÷ Revenue | +20.7% | -4.1% | -2.2% | +16.5% | +23.0% |
| FCF MarginFCF ÷ Revenue | +31.9% | +8.3% | +18.8% | +15.6% | +38.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.7% | +10.4% | +15.6% | +22.5% | +30.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +19.1% | +62.5% | +164.2% | +42.9% | +116.7% |
Valuation Metrics
CRUS leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, CRUS trades at a 76% valuation discount to ADI's 89.6x P/E. Adjusting for growth (PEG ratio), CRUS offers better value at 1.31x vs ADI's 13.15x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.8B | $4.1B | $55.0B | $25.8B | $199.4B |
| Enterprise ValueMkt cap + debt − cash | $8.1B | $4.6B | $59.9B | $26.3B | $205.6B |
| Trailing P/EPrice ÷ TTM EPS | 21.90x | -86.72x | -9999.00x | -471.88x | 89.59x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.94x | 23.88x | 64.79x | 76.91x | 35.77x |
| PEG RatioP/E ÷ EPS growth rate | 1.31x | — | — | — | 13.15x |
| EV / EBITDAEnterprise value multiple | 16.64x | 94.16x | 57.21x | 136.13x | 41.69x |
| Price / SalesMarket cap ÷ Revenue | 4.38x | 3.84x | 12.49x | 26.71x | 18.10x |
| Price / BookPrice ÷ Book value/share | 4.22x | 2.98x | 7.71x | 19.20x | 6.00x |
| Price / FCFMarket cap ÷ FCF | 13.76x | 38.84x | 71.19x | 134.01x | 46.61x |
Profitability & Efficiency
CRUS leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
CRUS delivers a 20.2% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-3 for SYNA. CRUS carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCHP's 0.80x. On the Piotroski fundamental quality scale (0–9), CRUS scores 8/9 vs MTSI's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.2% | -3.5% | -1.4% | +13.2% | +8.0% |
| ROA (TTM)Return on assets | +17.1% | -1.9% | -0.7% | +8.6% | +5.6% |
| ROICReturn on invested capital | +22.9% | -4.0% | +1.8% | +6.0% | +5.4% |
| ROCEReturn on capital employed | +20.8% | -3.9% | +2.1% | +7.6% | +6.5% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 5 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.06x | 0.63x | 0.80x | 0.41x | 0.26x |
| Net DebtTotal debt minus cash | -$667M | $489M | $4.9B | $426M | $6.2B |
| Cash & Equiv.Liquid assets | $801M | $392M | $772M | $112M | $2.5B |
| Total DebtShort + long-term debt | $134M | $880M | $5.7B | $538M | $8.7B |
| Interest CoverageEBIT ÷ Interest expense | 703.54x | -30.00x | 0.78x | 391.47x | 10.80x |
Total Returns (Dividends Reinvested)
MTSI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MTSI five years ago would be worth $61,359 today (with dividends reinvested), compared to $8,087 for SYNA. Over the past 12 months, MTSI leads with a +203.8% total return vs CRUS's +77.6%. The 3-year compound annual growth rate (CAGR) favors MTSI at 84.4% vs SYNA's 11.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +43.5% | +39.7% | +56.9% | +96.9% | +49.6% |
| 1-Year ReturnPast 12 months | +77.6% | +81.7% | +115.1% | +203.8% | +106.4% |
| 3-Year ReturnCumulative with dividends | +120.0% | +37.7% | +43.9% | +526.9% | +127.5% |
| 5-Year ReturnCumulative with dividends | +124.1% | -19.1% | +45.7% | +513.6% | +170.8% |
| 10-Year ReturnCumulative with dividends | +421.3% | +60.9% | +373.8% | +795.9% | +689.6% |
| CAGR (3Y)Annualised 3-year return | +30.1% | +11.2% | +12.9% | +84.4% | +31.5% |
Risk & Volatility
Evenly matched — CRUS and MCHP each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRUS is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than SYNA's 2.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 2.28x | 1.70x | 1.75x | 1.44x |
| 52-Week HighHighest price in past year | $179.00 | $110.43 | $103.17 | $355.00 | $415.97 |
| 52-Week LowLowest price in past year | $91.32 | $56.80 | $46.92 | $110.09 | $195.69 |
| % of 52W HighCurrent price vs 52-week peak | +95.9% | +95.8% | +98.5% | +97.0% | +98.2% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 76.5 | 82.5 | 71.3 | 73.1 |
| Avg Volume (50D)Average daily shares traded | 600K | 739K | 9.0M | 1.1M | 3.5M |
Analyst Outlook
Evenly matched — MCHP and ADI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CRUS as "Buy", SYNA as "Buy", MCHP as "Buy", MTSI as "Buy", ADI as "Buy". Consensus price targets imply -8.3% upside for ADI (target: $374) vs -26.3% for MTSI (target: $254). For income investors, MCHP offers the higher dividend yield at 1.79% vs ADI's 0.95%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $145.00 | $96.86 | $87.00 | $254.00 | $374.42 |
| # AnalystsCovering analysts | 22 | 32 | 46 | 23 | 54 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.8% | — | +0.9% |
| Dividend StreakConsecutive years of raises | 1 | — | 5 | 0 | 22 |
| Dividend / ShareAnnual DPS | — | — | $1.82 | — | $3.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.2% | +3.1% | +0.2% | +0.2% | +1.1% |
CRUS leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ADI leads in 1 (Income & Cash Flow). 2 tied.
CRUS vs SYNA vs MCHP vs MTSI vs ADI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CRUS or SYNA or MCHP or MTSI or ADI a better buy right now?
For growth investors, MACOM Technology Solutions Holdings, Inc.
(MTSI) is the stronger pick with 32. 6% revenue growth year-over-year, versus -42. 3% for Microchip Technology Incorporated (MCHP). Cirrus Logic, Inc. (CRUS) offers the better valuation at 21. 9x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Cirrus Logic, Inc. (CRUS) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRUS or SYNA or MCHP or MTSI or ADI?
On trailing P/E, Cirrus Logic, Inc.
(CRUS) is the cheapest at 21. 9x versus Analog Devices, Inc. at 89. 6x. On forward P/E, Cirrus Logic, Inc. is actually cheaper at 18. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cirrus Logic, Inc. wins at 1. 06x versus Analog Devices, Inc. 's 5. 25x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CRUS or SYNA or MCHP or MTSI or ADI?
Over the past 5 years, MACOM Technology Solutions Holdings, Inc.
(MTSI) delivered a total return of +513. 6%, compared to -19. 1% for Synaptics Incorporated (SYNA). Over 10 years, the gap is even starker: MTSI returned +795. 9% versus SYNA's +60. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRUS or SYNA or MCHP or MTSI or ADI?
By beta (market sensitivity over 5 years), Cirrus Logic, Inc.
(CRUS) is the lower-risk stock at 1. 12β versus Synaptics Incorporated's 2. 28β — meaning SYNA is approximately 104% more volatile than CRUS relative to the S&P 500. On balance sheet safety, Cirrus Logic, Inc. (CRUS) carries a lower debt/equity ratio of 6% versus 80% for Microchip Technology Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — CRUS or SYNA or MCHP or MTSI or ADI?
By revenue growth (latest reported year), MACOM Technology Solutions Holdings, Inc.
(MTSI) is pulling ahead at 32. 6% versus -42. 3% for Microchip Technology Incorporated (MCHP). On earnings-per-share growth, the picture is similar: Analog Devices, Inc. grew EPS 39. 0% year-over-year, compared to -170. 2% for MACOM Technology Solutions Holdings, Inc.. Over a 3-year CAGR, MTSI leads at 12. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRUS or SYNA or MCHP or MTSI or ADI?
Cirrus Logic, Inc.
(CRUS) is the more profitable company, earning 20. 7% net margin versus -5. 6% for MACOM Technology Solutions Holdings, Inc. — meaning it keeps 20. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADI leads at 26. 6% versus -8. 8% for SYNA. At the gross margin level — before operating expenses — ADI leads at 61. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRUS or SYNA or MCHP or MTSI or ADI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cirrus Logic, Inc. (CRUS) is the more undervalued stock at a PEG of 1. 06x versus Analog Devices, Inc. 's 5. 25x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Cirrus Logic, Inc. (CRUS) trades at 18. 9x forward P/E versus 76. 9x for MACOM Technology Solutions Holdings, Inc. — 58. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADI: -8. 3% to $374. 42.
08Which pays a better dividend — CRUS or SYNA or MCHP or MTSI or ADI?
In this comparison, MCHP (1.
8% yield), ADI (0. 9% yield) pay a dividend. CRUS, SYNA, MTSI do not pay a meaningful dividend and should not be held primarily for income.
09Is CRUS or SYNA or MCHP or MTSI or ADI better for a retirement portfolio?
For long-horizon retirement investors, Analog Devices, Inc.
(ADI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 9% yield, +689. 6% 10Y return). Synaptics Incorporated (SYNA) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ADI: +689. 6%, SYNA: +60. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRUS and SYNA and MCHP and MTSI and ADI?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CRUS is a small-cap quality compounder stock; SYNA is a small-cap quality compounder stock; MCHP is a mid-cap quality compounder stock; MTSI is a mid-cap high-growth stock; ADI is a mid-cap high-growth stock. MCHP, ADI pay a dividend while CRUS, SYNA, MTSI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.